285 results on '"Kruchko, Carol"'
Search Results
2. Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.
3. A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.
4. Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions.
5. Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex
6. Association Between Urbanicity and Outcomes Among Patients with Spinal Cord Ependymomas in the United States
7. Associations between urbanicity and spinal cord astrocytoma management and outcomes
8. European genetic ancestry associated with risk of childhood ependymoma
9. Changes in survival over time for primary brain and other CNS tumors in the United States, 2004–2017
10. Brain tumor epidemiology in the era of precision medicine: The 2017 Brain Tumor Epidemiology Consortium meeting report
11. Descriptive epidemiology of craniopharyngiomas in the United States
12. CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020.
13. The impact of COVID-19 on 2020 monthly incidence trends of primary brain and other CNS tumors.
14. Association of county-level socioeconomic status with meningioma incidence and outcomes.
15. Association between county-level socioeconomic status and the incidence of and surgical treatment for pituitary adenoma.
16. Geographic and temporal variations in the utilization of stereotactic radiosurgery for treatment of non-small cell lung cancer brain metastases from 2010 to 2015: An analysis of the national cancer database
17. Primary central nervous system lymphoma in patients with and without HIV infection : a multicenter study and comparison with U.S national data
18. Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study
19. Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015–2019.
20. Brain tumors in United States military veterans.
21. The impact of the COVID-19 pandemic on treatment patterns in glioblastoma.
22. Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT
23. Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015
24. Racial/ethnic differences in survival for patients with gliosarcoma: an analysis of the National cancer database
25. The epidemiology of central and extraventricular neurocytoma in the United States between 2006 and 2014
26. Primary brain and other central nervous system tumors in Appalachia: regional differences in incidence, mortality, and survival
27. Data Matching to Support Analysis of Cancer Epidemiology Among Veterans Compared With Non-Veteran Populations—An Exemplar in Brain Tumors
28. Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
29. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016—2020.
30. Do race and age vary in non-malignant central nervous system tumor incidences in the United States?
31. Complete prevalence of primary malignant and nonmalignant brain tumors in comparison to other cancers in the United States.
32. The association of Medicaid expansion and pediatric cancer overall survival.
33. Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013
34. Estimating the annual frequency of synchronous brain metastasis in the United States 2010–2013: a population-based study
35. Is mortality due to primary malignant brain and other central nervous system tumors decreasing?
36. Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report
37. Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004–2012, varying)
38. The joint impacts of sex and race/ethnicity on incidence of grade 1 versus grades 2-3 meningioma across the lifespan.
39. National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States.
40. Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995–2012
41. Incidence of vestibular schwannomas in the United States
42. Molecular marker testing and reporting completeness for adult-type diffuse gliomas in the United States.
43. Incidence and survival of choroid plexus tumors in the United States.
44. Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.
45. Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics.
46. The Central Brain Tumor Registry of the United States Histopathological Grouping Scheme Provides Clinically Relevant Brain and Other Central Nervous System Categories for Cancer Registry Data.
47. Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004–2011
48. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019.
49. CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018.
50. Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.